Chemigraphic, the provider of Electronic Manufacturing Services (EMS) to the fast-growth medical technology, defence and power systems sectors, today announces the arrival of a new Chairman of the board, Geraint Anderson, and a new finance director, Kevin Docherty.
These key appointments are the latest developments for the Crawley based business, which received £7m investment from PE fund, NVM, in July this year. The investment will help to support Chemigraphic’s global expansion and drive continued development of its technology and expertise, particularly in the fast-growing med-tech sector.
Chris Wootton, CEO of Chemigraphic, comments: “As we continue to grow the business and our capabilities in order to support our customers both in the UK and globally, it’s essential we have the right talent on board to help us achieve this. Geraint and Kevin are highly experienced and exceptional individuals that will strengthen the board significantly.
Headquartered in Crawley’s prestigious Manor Royal business park, with a sourcing office in China, Chemigraphic builds complex products for a wide range of specialist UK and global technology brands, from conception to production, supporting them at every stage of their product lifecycle. With over 150 staff and experience spanning over four decades, Chemigraphic is now set for a period of strong growth, which has been boosted further by the NVM investment.
